Sinovac Biotech Ltd. (NASDAQ:SVA)
CAPS Rating:
A biopharmaceutical company which is in the business of research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.
RSS Headlines
Fool UK
Recs
could be a multibagger, high insider ownership, 46% eps 3yrs, 43% rev. growth 3yrs, plus upcoming trials